Boston Partners
AZN icon

Boston Partners’s AstraZeneca AZN Stock Holding History

Boston Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597M Buy
3,177,627
+1,083,731
+52% +$204M 0.53% 55
2026
Q1 		$413M Sell
2,093,896
-21,000
-1% -$4.05M 0.43% 79
2025
Q4 		$389M Sell
2,114,896
-508,829
-19% -$89.2M 0.4% 84
2025
Q3 		$405M Buy
2,623,725
+128,763
+5% +$19.5M 0.42% 79
2025
Q2 		$350M Sell
2,494,962
-23,361
-0.9% -$3.27M 0.39% 82
2025
Q1 		$369M Buy
2,518,323
+664,583
+36% +$96.2M 0.45% 73
2024
Q4 		$243M Buy
1,853,740
+1,835,360
+9,986% +$257M 0.3% 131
2024
Q3 		$2.86M Buy
18,380
+16,407
+832% +$2.65M ﹤0.01% 478
2024
Q2 		$309K Sell
1,973
-272
-12% -$40.9K ﹤0.01% 687
2024
Q1 		$309K Buy
+2,245
New +$297K ﹤0.01% 733
2023
Q4 		– Sell
-1,554
Closed -$210K – 712
2023
Q3 		$210K Buy
1,554
+29
+2% +$3.96K ﹤0.01% 701
2023
Q2 		$218K Sell
1,525
-293
-16% -$43.1K ﹤0.01% 686
2023
Q1 		$252K Buy
+1,818
New +$245K ﹤0.01% 660
2014
Q1 		– Sell
-331,935
Closed -$19.7M – 719
2013
Q4 		$19.7M Sell
331,935
-2,294,117
-87% -$125M 0.04% 283
2013
Q3 		$136M Buy
2,626,052
+2,532,101
+2,695% +$127M 0.33% 97
2013
Q2 		$4.44M Buy
+93,951
New +$4.78M 0.01% 497

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boston Partners's AZN Position: Q2 2026 in Review

Boston Partners increased its AstraZeneca (AZN) stake by 52% in Q2 2026, buying an estimated $204M and bringing the position to 3,177,627 shares worth $597M. The position accounts for 0.53% of the portfolio, ranked #55.

Boston Partners first reported a position in AZN in Q2 2013 and has held it in 16 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Boston Partners held 3,177,627 shares of AstraZeneca worth $597M as of Q2 2026.
  • Boston Partners bought 1,083,731 AstraZeneca shares in Q2 2026, an estimated $204M.
  • AstraZeneca made up 0.53% of Boston Partners's portfolio in Q2 2026, its #55 holding.
  • Boston Partners first reported a position in AstraZeneca in Q2 2013 and has held it in 16 quarters since.
  • 1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.